BIOMARKER:

IDH1 R132C

Entrez ID:

Related biomarkers:

‹

›

IDH1 R132C IDH1 R132C	Cholangiocarcinoma Cholangiocarcinoma	ivosidenib Sensitive: C2 – Inclusion Criteria
IDH1 R132C IDH1 R132C	Non Small Cell Lung Cancer NSCLC	trametinib + dabrafenib Sensitive: C3 – Early Trials
IDH1 R132C IDH1 R132C	Cholangiocarcinoma Cholangiocarcinoma	dasatinib Sensitive: D – Preclinical
IDH1 R132C IDH1 R132C	Acute Myelogenous Leukemia AML	GSK321 Sensitive: D – Preclinical

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

Associations